We are live on ! Find out more
KCM

Kennedy Capital Management Portfolio holdings

AUM $4.72B
1-Year Est. Return 36.69%
This Fund
S&P 500
This Quarter Est. Return
+12.41%
1 Year Est. Return
+36.69%
3 Year Est. Return
+98.85%
5 Year Est. Return
+128.89%
10 Year Est. Return
+548.51%
AUM
$4.74B
AUM Growth
+$280M
Cap. Flow
-$135M
Cap. Flow %
-2.85%
Top 10 Hldgs %
8.1%
Holding
673
New
46
Increased
156
Reduced
400
Closed
62

Sector Composition

Rank Sector Weight
1 Financials 22.07%
2 Industrials 15.94%
3 Technology 13.34%
4 Consumer Discretionary 11.72%
5 Real Estate 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CECO icon
501
Ceco Environmental
CECO
$4.11B
$1.14M 0.02%
182,190
-18,506
-9% -$123K
PHM icon
502
Pultegroup
PHM
$24.8B
$1.13M 0.02%
19,742
+2,934
+17% +$150K
CALB
503
DELISTED
California BanCorp Common Stock
CALB
$1.13M 0.02%
53,040
+3,091
+6% +$58K
VVX icon
504
V2X
VVX
$2.6B
$1.12M 0.02%
24,489
-2,494
-9% -$118K
NNBR icon
505
NN Inc
NNBR
$300M
$1.09M 0.02%
267,091
-26,968
-9% -$132K
CLDX icon
506
Celldex Therapeutics
CLDX
$3.37B
$1.09M 0.02%
+28,158
New +$1.23M
EHC icon
507
Encompass Health
EHC
$12.4B
$1.08M 0.02%
20,719
-1,707
-8% -$88.1K
VOYA icon
508
Voya Financial
VOYA
$9.08B
$1.07M 0.02%
16,090
-1,058
-6% -$69.7K
MNSB icon
509
MainStreet Bancshares
MNSB
$172M
$1.05M 0.02%
42,731
+160
+0.4% +$3.89K
ICLR icon
510
Icon
ICLR
$12.8B
$1.05M 0.02%
3,391
-1,259
-27% -$352K
SSBK
511
DELISTED
Southern States Bancshares
SSBK
$1.04M 0.02%
53,092
+2,964
+6% +$58K
SENEA icon
512
Seneca Foods Class A
SENEA
$1.22B
$1.03M 0.02%
21,587
-2,183
-9% -$107K
TPTX
513
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$1.03M 0.02%
21,698
+4,487
+26% +$201K
CRDF icon
514
Cardiff Oncology
CRDF
$80.1M
$1.02M 0.02%
170,447
-5,380
-3% -$32.1K
FARO
515
DELISTED
Faro Technologies
FARO
$1.02M 0.02%
14,599
+1,004
+7% +$72.2K
SBT
516
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$1.02M 0.02%
176,621
+75,214
+74% +$403K
TCFC
517
DELISTED
The Community Financial Corporation Common Stock
TCFC
$985K 0.02%
25,048
-37
-0.1% -$1.42K
HARP
518
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$980K 0.02%
+12,977
New +$886K
APRE icon
519
Aprea Therapeutics
APRE
$7.98M
$966K 0.02%
16,837
-287
-2% -$25.4K
POOL icon
520
Pool Corp
POOL
$7.27B
$944K 0.02%
1,668
-142
-8% -$74.4K
HI
521
DELISTED
Hillenbrand
HI
$942K 0.02%
18,113
-1,200
-6% -$57.3K
USCB icon
522
USCB Financial Holdings
USCB
$408M
$932K 0.02%
66,527
-20,202
-23% -$280K
NKSH icon
523
National Bankshares
NKSH
$257M
$925K 0.02%
25,815
+32
+0.1% +$1.18K
BW icon
524
Babcock & Wilcox
BW
$1.32B
$910K 0.02%
100,874
-3,904
-4% -$31.3K
BRO icon
525
Brown & Brown
BRO
$24B
$905K 0.02%
12,883
-1,098
-8% -$70.8K

Similar funds

Kennedy Capital Management's Q4 2021 Portfolio in Review

As of Q4 2021, Kennedy Capital Management held 673 positions worth $4.74B, up 6.3% from $4.46B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.

Kennedy Capital Management's Q4 2021 filing shows 46 new, 156 increased, 400 reduced and 62 closed positions. Its largest new stake was Cadence Bank: 922,847 shares worth $27.5M. The largest sale was Cadence Bancorporation, an estimated $28.2M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Industrials and Technology.

  • Kennedy Capital Management's largest Q4 2021 buy was Cadence Bank: 922,847 shares worth $27.5M.
  • Kennedy Capital Management added most to Kite Realty in Q4 2021, an estimated $14.9M increase.
  • Kennedy Capital Management's biggest Q4 2021 reduction was The Shyft Group, cutting an estimated $17.6M.
  • Kennedy Capital Management fully exited Cadence Bancorporation in Q4 2021, selling an estimated $28.2M.
  • Kennedy Capital Management's ten largest holdings make up 8.1% of its $4.74B portfolio in Q4 2021.
  • Kennedy Capital Management opened 46 new positions and closed 62 in Q4 2021.
  • Kennedy Capital Management's portfolio value rose 6.3% quarter-over-quarter to $4.74B.

Based on Kennedy Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.